Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 19 filings.
24 Aug 2026 1 filing
Instruments and ratings
Long-term bank facilities ₹3.00 crore rated CARE BBB-, Stable; reaffirmed.
Short-term bank facilities ₹9.00 crore rated CARE A3; reaffirmed.
Rationale and outlook
Rationale: reaffirmation based on FY26 audited and Q1FY27 unaudited performance.
Outlook for the long-term rating: Stable; short-term outlook not disclosed.
Total rated facilities: ₹12.00 crore.
Agency: CARE Ratings Limited (CareEdge Ratings).
Material changes since last rating: None.
14 Aug 2026 1 filing
AGM Details
34th AGM scheduled for Sep 8, 2026 at 12:30 PM via VC/OAVM.
Dividend & TDS
Dividend payment planned; TDS on dividend applicable.
Book Closure
Book closure dates communicated in the notice.
Record Date
Record date for dividend to be announced.
Accessibility
Notice and Annual Report for FY2025-26 available online.
13 Aug 2026 1 filing
Financial snapshot
Revenue from operations: ₹10,572.89 Lakhs.
Total revenue: ₹10,836.72 Lakhs.
Profit before tax: ₹1,087.38 Lakhs.
Profit after tax: ₹804.71 Lakhs.
EPS: ₹13.52 (basic & diluted).
Business mix & geography
Export contributed about 56% of revenue.
Geography: India ₹4,675.18 Lakhs; Overseas ₹5,856.30 Lakhs.
Manufacturing segment revenue ₹173,400.70 thousand; Trading ₹879,747.60 thousand.
Dividend & capital allocation
Final dividend proposed: ₹1.30 per equity share.
Record date: 01-Sep-2026; payment by 07-Oct-2026 if approved.
Total dividend outgo on approval: ₹77,38,900.
No general reserve transfer in FY2025-26.
Capital structure & liquidity
Borrowings (current): ₹73,100.00 thousand.
Cash and cash equivalents: ₹1,054.16 thousand.
Fixed deposits: ₹120,782.68 thousand.
Debt-equity ratio: 0.00x; Current ratio: 4.01x.
Governance & board changes
Amardeep Singh Ahluwalia appointed Independent Director for 5 years from 08-Sep-2026.
Ashok Kumar Dangaich retired by rotation; not reappointed.
Board met 5 times; Audit Committee met 4 times; Nomination & Remuneration met 2 times.
Audit, controls & governance flags
Statutory Auditor: Gourisaria Goyal & Co; Secretarial Auditor: Arms & Associates LLP.
No adverse audit remarks; no fraud reported.
Internal controls deemed adequate and effective.
CSR & ESG
CSR spend: ₹19,96,738; two-percent net profit obligation: ₹18,55,200.
Excess CSR spend: ₹1,41,541; carry forward ₹2,61,642.
CSR activities include social activity and heritage.
Outlook & risks
Outlook remains cautiously optimistic; risks include raw material prices and currency volatility.
Management focuses on product diversification and market expansion.
12 Aug 2026 2 filings
AGM notice advertisement
Newspaper ad published on 12.08.2026 in Financial Express and Business Remedies ahead of AGM notice.
Informs on e-mail registration/updation to receive AGM Notice and Annual Report electronically.
Notice and related information also posted on the company website.
Publication of unaudited Q1 2026 results
Submission of newspaper publication of unaudited Q1 2026 results for quarter ended 30.06.2026.
Publication in Financial Express (English) and Business Remedies (Hindi) editions.
10 Aug 2026 3 filings
Book closure and AGM
Book closure from 02-09-2026 to 08-09-2026 (inclusive) for AGM notice and remote e-voting eligibility.
AGM scheduled for 08 September 2026 at 12:30 PM via VC/OAVM.
Financials and AGM actions
Standalone Audited Financial Statements for the quarter ended 30 June 2026 approved.
Limited Review Report on the same financials placed on record.
34th AGM scheduled for 08 September 2026 at 12:30 PM via VC/OAVM.
Notice for 34th AGM approved.
Board Report including Corporate Governance Report for 2025-26 approved.
Scrutinizer appointed for e-voting at the AGM.
Record date for dividend payment fixed as 01 September 2026.
Other matters as per agenda.
Financials
Revenue from operations: 3,889.98; other income: 49.70; total revenue: 3,939.08 lakhs.
Total expenses: 3,609.66; profit before tax: 329.42.
Tax expense: current 82.97; deferred 0.57; PAT: 246.51.
EPS basic/diluted: 4.14.
Board approved standalone unaudited results; auditors issued unmodified limited review.
Quarter ended 30.06.2026; as per SEBI LODR Regulation 33.
Segment & Balance Sheet
Manufacturing revenue: 397.64; Trading revenue: 3,473.38; total segment revenue: 3,871.02.
Segment profit: Manufacturing 61.88; Trading 342.44; total segment PBT: 404.32.
Net PBT before tax: 329.42; finance cost: 15.75; unallocable expenditure net: 59.15.
Total segment assets: 3,819.97; unallocable assets: 1,761; net segment assets: 5,580.97.
Total segment liabilities: 188.53; unallocable liabilities: 5,392.44; net segment liabilities: 5,580.97.
Audit & Notes
Limited Review Report by Gourisaria Goyal & Co; unmodified opinion.
Notes: two primary segments manufacturing and trading; board approved on 10.08.2026.
7 Jul 2026 1 filing
Dematerialisation actions and listing
Securities dematerialised during the period have been processed; details furnished to depositories and stock exchanges.
Securities received for dematerialisation were mutilated, cancelled within prescribed time after verification, and depository substituted as registered owner.
Dematerialised securities are listed on the stock exchanges where earlier issues were listed.